Recombinant high-density lipoproteins and their use in cardiovascular diseases

被引：17
作者：
Cao, Yi-ni [1 ,2 ]
Xu, Lu [1 ,2 ]
Han, Ying-chun [1 ,2 ]
Wang, Yu-nan [1 ,2 ]
Liu, George [1 ,2 ]
Qi, Rong [1 ,2 ]
机构：
[1] Peking Univ, Hlth Sci Ctr, Inst Cardiovasc Sci, 38 Xueyuan Rd, Beijing 100191, Peoples R China
[2] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China
来源：
DRUG DISCOVERY TODAY | 2017年 / 22卷 / 01期
基金：
中国国家自然科学基金;
关键词：
APOLIPOPROTEIN-A-I; AMPHIPATHIC HELICAL PEPTIDE; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; HERITABLE HYPERLIPIDEMIC RABBITS; RANDOMIZED CONTROLLED-TRIAL; APOA-I; MIMETIC PEPTIDE; ANTIINFLAMMATORY PROPERTIES; CORONARY ATHEROSCLEROSIS; BIOLOGICAL-PROPERTIES;
D O I：
10.1016/j.drudis.2016.08.010
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The unique anti-atherosclerosis abilities and other cardioprotective properties make high-density lipoprotein (HDL) a promising solution in treating cardiovascular diseases. A number of studies showed that HDL-based therapy was well tolerated and has great potential in the future. Among all these new agents, the most studied ones including recombinant HDL, recombinant human apolipoproteins, apolipoprotein mimetic peptides and recombinant HDL used as contrast agents in cardiovascular imaging are discussed here. Recombinant HDL and apolipoproteins are promising in diagnosing and treating cardiovascular diseases.
引用
收藏
页码：180 / 185
页数：6
相关论文
共 57 条
[1]   RECOMBINANT APOLIPOPROTEIN-A-I MILANO REDUCES INTIMAL THICKENING AFTER BALLOON INJURY IN HYPERCHOLESTEROLEMIC RABBITS [J].
AMELI, S ;
HULTGARDHNILSSON, A ;
CERCEK, B ;
SHAH, PK ;
FORRESTER, JS ;
AGELAND, H ;
NILSSON, J .
CIRCULATION, 1994, 90 (04) :1935-1941
[2]   Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides [J].
Anantharamaiah, G. M. ;
Mishra, Vinod K. ;
Garber, David W. ;
Datta, Geeta ;
Handattu, Shaila P. ;
Palgunachari, Mayakonda N. ;
Chaddha, Manjula ;
Navab, Mohamad ;
Reddy, Srinivasa T. ;
Segrest, Jere P. ;
Fogelman, Alan M. .
JOURNAL OF LIPID RESEARCH, 2007, 48 (09) :1915-1923
[3]   USE OF SYNTHETIC PEPTIDE ANALOGS TO LOCALIZE LECITHIN-CHOLESTEROL ACYLTRANSFERASE ACTIVATING DOMAIN IN APOLIPOPROTEIN-A-I [J].
ANANTHARAMAIAH, GM ;
VENKATACHALAPATHI, YV ;
BROUILLETTE, CG ;
SEGREST, JP .
ARTERIOSCLEROSIS, 1990, 10 (01) :95-105
[4]  
ANANTHARAMAIAH GM, 1985, J BIOL CHEM, V260, P248
[5]   PROLIFERATION OF THYROTROPIN-RELEASING-HORMONE RECEPTORS IN SPECIFIC BRAIN-REGIONS DURING THE DEVELOPMENT OF HYPERTENSION IN SPONTANEOUSLY HYPERTENSIVE RATS [J].
BHARGAVA, HN ;
DAS, S ;
BANSINATH, M .
PEPTIDES, 1987, 8 (02) :231-235
[6]   A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice [J].
Bielicki, John K. ;
Zhang, Haiyan ;
Cortez, Yuan ;
Zheng, Ying ;
Narayanaswami, Vasanthy ;
Patel, Arti ;
Johansson, Jan ;
Azhar, Salman .
JOURNAL OF LIPID RESEARCH, 2010, 51 (06) :1496-1503
[7]   Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients [J].
Bloedon, LeAnne T. ;
Dunbar, Richard ;
Duffy, Danielle ;
Pinell-Salles, Paula ;
Norris, Robert ;
DeGroot, Bruce J. ;
Movva, Rajesh ;
Navab, Mohamad ;
Fogelman, Alan M. ;
Rader, Daniel J. .
JOURNAL OF LIPID RESEARCH, 2008, 49 (06) :1344-1352
[8]  
Boden WE, 2000, AM J CARDIOL, V86, p19L
[9]   AMINO-ACID SEQUENCE OF HUMAN APOA-I, AN APOLIPOPROTEIN ISOLATED FROM HIGH-DENSITY LIPOPROTEINS [J].
BREWER, HB ;
FAIRWELL, T ;
LARUE, A ;
RONAN, R ;
HOUSER, A ;
BRONZERT, TJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1978, 80 (03) :623-630
[10]   HDL as a treatment target [J].
Brown, W. Virgil ;
Brewer, H. Bryan ;
Rader, Daniel J. ;
Schaefer, Ernst J. .
JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (01) :5-16
123456